Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy

Published:1998-08 Issue:2 Volume:54 Page:618-626
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Cannella Giuseppe,Paoletti Ernesto,Barocci Sergio,Massarino Fabio,Delfino Roberto,Ravera Giambattista,Di Maio Giovanni,Nocera Arcangelo,Patrone Pietro,Rolla Davide

Publisher

Elsevier BV

Subject

Nephrology

Reference45 articles.

1. Left ventricular dysfunction in end-stage renal disease. Echocardiographic insights,;London,1992

2. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy;Cannella;Kidney Int,1993

3. Myocardial hypertrophy in chronic renal failure: A multifactorial, reversible alteration;Cannella;Contrib Nephrol,1996

4. Prolonged therapy with ACE-inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremics independently from hypotensive effects;Cannella;Am J Kidney Dis,1997

5. Pathophysiology of left ventricular hypertrophy,;Messerli,1992

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiremodeling Efficacy of Zofenopril in Patientswith Arterial Hypertension Taking into Account I/D Polymorphism of the ACE Gene;Кардиология в Беларуси;2020-11-13

2. Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response;Journal of Translational Medicine;2012-03-13

3. Heart failure in patients on dialysis. A review of the issue and proposed therapeutic algorithm;Cor et Vasa;2010-04-01

4. Long-Term Evolution and Changing Associations of Left Ventricular Hypertrophy after Starting Hemodialysis;Nephron Clinical Practice;2008

5. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?;Pharmacology & Therapeutics;2007-03